Adaptive functioning in pediatric brain tumor survivors: An examination of ethnicity and socioeconomic status.
adaptive functioning
brain tumor
ethnicity
radiation
socioeconomic status
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
17
02
2019
revised:
11
04
2019
accepted:
18
04
2019
pubmed:
28
5
2019
medline:
23
1
2020
entrez:
29
5
2019
Statut:
ppublish
Résumé
Survivors of pediatric brain tumor are at risk for adaptive difficulties. The present study examined adaptive functioning in a multiethnic sample of survivors accounting for socioeconomic status, and whether demographic, diagnostic, and/or treatment-related variables predict adaptive outcomes. Participants included a multiethnic sample of survivors (58 Caucasian, 34 Hispanic, and 22 other non-Caucasian; M age = 14.05 years, SD = 4.33) who were approximately seven years post-treatment. Parents rated adaptive functioning and provided demographic information. Diagnostic and treatment-related information was abstracted from the electronic medical record. Parent ratings of adaptive functioning were similar across Caucasian, Hispanic, and other non-Caucasian survivors covarying for family income and primary caregiver education, both of which served as proxies for socioeconomic status. All ethnic groups were rated lower than the normative mean in overall adaptive functioning as well as the specific domains of conceptual, social, and practical skills. Demographic, diagnostic, and treatment-related variables were differentially associated with adaptive functioning in survivors of pediatric brain tumor, though socioeconomic status emerged as a strong significant predictor of adaptive functioning domains. Adaptive outcomes do not differ as a function of ethnicity after accounting for primary caregiver education and family income. Racial and ethnic minorities may be at increased risk for poorer outcomes given their overrepresentation at lower income levels. Assessing demographic and treatment-related variables early on may be helpful in identifying children likely to develop adaptive difficulties.
Sections du résumé
BACKGROUND
Survivors of pediatric brain tumor are at risk for adaptive difficulties. The present study examined adaptive functioning in a multiethnic sample of survivors accounting for socioeconomic status, and whether demographic, diagnostic, and/or treatment-related variables predict adaptive outcomes.
METHOD
Participants included a multiethnic sample of survivors (58 Caucasian, 34 Hispanic, and 22 other non-Caucasian; M age = 14.05 years, SD = 4.33) who were approximately seven years post-treatment. Parents rated adaptive functioning and provided demographic information. Diagnostic and treatment-related information was abstracted from the electronic medical record.
RESULTS
Parent ratings of adaptive functioning were similar across Caucasian, Hispanic, and other non-Caucasian survivors covarying for family income and primary caregiver education, both of which served as proxies for socioeconomic status. All ethnic groups were rated lower than the normative mean in overall adaptive functioning as well as the specific domains of conceptual, social, and practical skills. Demographic, diagnostic, and treatment-related variables were differentially associated with adaptive functioning in survivors of pediatric brain tumor, though socioeconomic status emerged as a strong significant predictor of adaptive functioning domains.
CONCLUSIONS
Adaptive outcomes do not differ as a function of ethnicity after accounting for primary caregiver education and family income. Racial and ethnic minorities may be at increased risk for poorer outcomes given their overrepresentation at lower income levels. Assessing demographic and treatment-related variables early on may be helpful in identifying children likely to develop adaptive difficulties.
Identifiants
pubmed: 31134755
doi: 10.1002/pbc.27800
pmc: PMC6730637
mid: NIHMS1026413
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e27800Subventions
Organisme : NCI NIH HHS
ID : K07 CA157923
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA187202
Pays : United States
Informations de copyright
© 2019 Wiley Periodicals, Inc.
Références
Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1301-6
pubmed: 23245284
J Fam Psychol. 2005 Jun;19(2):294-304
pubmed: 15982107
J Clin Oncol. 2008 Aug 20;26(24):3965-70
pubmed: 18711186
Ann Intern Med. 2005 Nov 1;143(9):639-47
pubmed: 16263886
J Fam Psychol. 2004 Dec;18(4):651-7
pubmed: 15598170
J Clin Exp Neuropsychol. 1992 Jul;14(4):593-609
pubmed: 1400921
Pediatr Blood Cancer. 2018 Sep;65(9):e27245
pubmed: 29856521
Brain Imaging Behav. 2010 Dec;4(3-4):256-69
pubmed: 20814845
Radiother Oncol. 2017 Jul;124(1):89-97
pubmed: 28655455
J Neurooncol. 2016 Sep;129(2):311-7
pubmed: 27311729
Med Pediatr Oncol. 2003 Jan;40(1):26-34
pubmed: 12426683
Child Dev. 2003 Sep-Oct;74(5):1368-78
pubmed: 14552403
Pediatr Blood Cancer. 2015 Mar;62(3):509-16
pubmed: 25400011
Am Psychol. 1992 Jun;47(6):723-9
pubmed: 1616171
Pediatr Blood Cancer. 2013 Oct;60(10):1696-702
pubmed: 23733619
Neuro Oncol. 2014 Dec;16(12):1652-60
pubmed: 24908655
J Neurooncol. 2014 May;118(1):193-9
pubmed: 24658934
Psychooncology. 2013 Sep;22(9):1979-86
pubmed: 23447439
Neuropsychol Rev. 2001 Dec;11(4):169-78
pubmed: 11883667
Pediatr Blood Cancer. 2018 Feb;65(2):
pubmed: 28988412
JAMA. 2005 Dec 14;294(22):2879-88
pubmed: 16352796
Pediatr Blood Cancer. 2007 Sep;49(3):298-305
pubmed: 16779805
J Clin Oncol. 2009 Aug 1;27(22):3691-7
pubmed: 19581535
Psychooncology. 2018 Jan;27(1):178-186
pubmed: 28171696
Pediatr Blood Cancer. 2011 Jul 15;57(1):110-8
pubmed: 21337681
J Health Commun. 2010;15 Suppl 3:252-63
pubmed: 21154097
Future Child. 1997 Summer-Fall;7(2):55-71
pubmed: 9299837
Child Dev. 1996 Oct;67(5):1891-914
pubmed: 9022222
Dev Sci. 2007 Jul;10(4):464-80
pubmed: 17552936
Clin Neuropsychol. 2017 Feb;31(2):307-328
pubmed: 27705087
Cancer. 2003 May 15;97(10):2512-9
pubmed: 12733151